Genprex, Inc. (GNPX)
3.53
-0.01
(-0.28%)
USD |
NASDAQ |
Sep 09, 10:55
Genprex Shareholders Equity (Quarterly) : 14.80M for June 30, 2026
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 14.80M |
| March 31, 2026 | 16.93M |
| December 31, 2025 | 7.962M |
| September 30, 2025 | 0.7678M |
| June 30, 2025 | 1.391M |
| March 31, 2025 | 3.868M |
| December 31, 2024 | 1.620M |
| September 30, 2024 | 1.665M |
| June 30, 2024 | 4.346M |
| March 31, 2024 | 8.757M |
| December 31, 2023 | 7.416M |
| September 30, 2023 | 12.31M |
| June 30, 2023 | 12.05M |
| March 31, 2023 | 18.48M |
| December 31, 2022 | 22.27M |
| September 30, 2022 | 27.49M |
| June 30, 2022 | 32.41M |
| March 31, 2022 | 37.02M |
| December 31, 2021 | 41.28M |
| September 30, 2021 | 45.17M |
| Date | Value |
|---|---|
| June 30, 2021 | 47.68M |
| March 31, 2021 | 50.42M |
| December 31, 2020 | 30.92M |
| September 30, 2020 | 22.98M |
| June 30, 2020 | 24.51M |
| March 31, 2020 | 23.94M |
| December 31, 2019 | 3.024M |
| September 30, 2019 | 3.531M |
| June 30, 2019 | 5.325M |
| March 31, 2019 | 7.245M |
| December 31, 2018 | 8.881M |
| September 30, 2018 | 10.48M |
| June 30, 2018 | 12.59M |
| March 31, 2018 | -0.0419M |
| December 31, 2017 | 0.4286M |
| September 30, 2017 | 0.8715M |
| June 30, 2017 | |
| March 31, 2017 | |
| December 31, 2016 | 1.625M |
Shareholders' Equity Definition
Represents the value of Shareholders' Equity as of the close of the report date, belonging to both Preferred and Common Equity Shareholders.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 1.307B |
| Alnylam Pharmaceuticals, Inc. | 1.354B |
| Anika Therapeutics, Inc. | 137.28M |
| Savara, Inc. | 143.66M |
| Vericel Corp. | 370.04M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 17.14M |
| Total Liabilities (Quarterly) | 2.342M |
| Current Ratio | 6.765 |